Editorial: DNA repair and nucleic acid therapeutics in cancer.
Editorial: DNA repair and nucleic acid therapeutics in cancer.
复制标题
作者:
NAR Cancer is pleased to publish a collection of articles [ https://academic. oup. com/narcancer/pages/dna-repair-andnucleic-acids-therapeutics] highlighting the breakthroughs and promise of targeting DNA Repair and DNA damage re-sponse mechanisms centered around the theme of ‘DNA Repair and Nucleic Acid Therapeutics in Cancer’. Eleven review articles provide insights into DNA repair mechanisms that impact genome stability and tumorigenesis, outline current and future cancer therapeutic options focused on DNA damage and repair mechanisms, and highlight methods to advance our understanding of the crosstalk among DNA repair and DNA damage response proteins and pathways. The online collection also includes links to> 40 Standard Articles on DNA repair and nucleic acids therapeutic-related topics that NAR Cancer has published since its inception in 2020.Human exposure to dangerous genotoxins is unavoidable, as DNA damaging agents are ubiquitous both in our environment and within our cells (1, 2). DNA damaging agents and other genotoxins that arise from cellular metabolism, environmental sources or disease-related cellular defects contribute to cell death, gene mutations, gene rearrangements and in many cases, the onset of cancer, disease, and aging phenotypes (3–6). Maintenance of the genome is therefore dependent on error-free DNA replication, RNA transcription and telomere stability. This is accomplished by a complex network of DNA repair and response mechanisms able to respond to DNA insults from both endogenous and exogenous genotoxins. This network of protein machines, engaged and activated in response to numerous types of genome damage, is referred to as the DNA damage response (DDR)(7).